2012
|
Invention
|
Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators. The present invention gene... |
2011
|
Invention
|
Pyrazoles for the treatment of obesity and other cns disorders. This invention relates to compoun... |
|
Invention
|
2c receptor ligands and uses thereof. 2c) is desired (e.g. addiction, anxiety, depression, obesit... |
2010
|
Invention
|
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep di... |
2008
|
Invention
|
Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators. T... |
2007
|
Invention
|
Workflow applications.
A facility is described for enabling workflow applications. The facility ... |
|
Invention
|
Pyrazoles for the treatment of obesity and other cns disorders. This invention relates to c... |
|
Invention
|
Mapc treatment of brain injuries and diseases. The invention relates to the treatment of various ... |
|
Invention
|
Mapc therapeutics without adjunctive immunosuppressive treatment. The invention relates to the tr... |
|
Invention
|
Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof. The... |
|
Invention
|
Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof. The prese... |
2006
|
Invention
|
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof. Isolated cell... |
|
Invention
|
Culture of non-embryonic cells at high cell density. The present invention is directed to the cul... |
|
Invention
|
Use of a gsk-3 inhibitor to maintain potency of cultured cells. The present invention is directed... |
2005
|
Invention
|
4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and... |
|
Invention
|
Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof. The invention r... |
|
Invention
|
Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof. The invention relates ... |
|
Invention
|
Compositions and methods for non-targeted activation of endogenous genes.
The present invention ... |
|
Invention
|
Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators. The present inventio... |
|
Invention
|
Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators.
The present invention gen... |
|
Invention
|
Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof. Acrylic n-hydroxy im... |
|
Invention
|
Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof. Acylic n-hydroxy imi... |
|
Invention
|
Substituted azepine derivatives as serotonin receptor modulators. The present invention generally... |
|
Invention
|
Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive a... |
|
Invention
|
Substituted azepine derivatives as serotonin receptor modulators. The present invention ge... |
2004
|
Invention
|
Benzo⏧1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making a... |
|
Invention
|
Enhanced engineered chromosome formation from alpha satellite with artificially increased density... |
2003
|
Invention
|
Methods for using osteocalcin. The present invention relates to methods for using osteocalcin. Th... |
|
Invention
|
Calcium-sensing receptor 2 (car2) and methods for using. The current disclosure provide a novel h... |
|
Invention
|
Benzo[1,3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and usi... |
|
Invention
|
compositions and methods for making mutations in cell lines and animals
. The present ... |
2002
|
Invention
|
Methods for using adamts-12, an integrin and metalloprotease with thrombspondin motifs. The prese... |
2000
|
Invention
|
Compositions and methods for non-targeted activation of endogenous genes. The present invention i... |
1999
|
Invention
|
Compositions and methods for non-targeted activation of endogenous genes. The field of the invent... |